Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

Fig. 5

Overall and progression-free survival dependent on gene expression of AURKA, RAD50 and DDB2. Low expression of AURKA and high expression of RAD50 and DDB2 resulted in prolonged overall survival (A-C). Low expression of AURKA (D) also resulted in prolonged progression-free survival with p < 0.0030. Low expression is highlighted in red, high expression is highlighted in green. The median was used to set a cut-off between high and low gene expression

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us